Status quo and prospect of metabolomics in diagnosis of thyroid cancer
10.3760/cma.j.issn.2095-4255.2018.08.021
- VernacularTitle:甲状腺癌代谢组学诊断研究现状及展望
- Author:
Fengqian WANG
1
;
Qiushi TIAN
;
Lijun FAN
Author Information
1. 哈尔滨医科大学公共卫生学院食品药品安全评价中心
- Keywords:
Thyroid cancer;
Metabolomics;
Biomarkers;
Metabolites
- From:
Chinese Journal of Endemiology
2018;37(8):686-688
- CountryChina
- Language:Chinese
-
Abstract:
Metabolomics is a study for comprehensive and systematic description of all small metabolites in biological samples. Metabolomics has obvious advantages in the diagnosis of diseases through the changes of internal and external environment of endogenous metabolites. Metabolomics provides the informative clue for diagnosing malignant tumor. In recent years, studies on thyroid cancer metabolomics have found that small molecular metabolites play a guiding role in diagnosis of the disease. In this paper, the application of metabolomics in diagnosis of thyroid carcinoma will be reviewed.
